Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Monogram Technologies Inc. Regulatory Filings 2021

Jan 13, 2021

33540_rns_2021-01-12_68c251a9-0487-4dcd-98ac-978b34bebb66.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

CORRESP 1 filename1.htm

Celeste M. Murphy

Office Chief

Office of Life Sciences

Division of Corporation Finance

Securities and Exchange Commission

Washington DC 20549

January 12, 2021

Re:
Amended Offering Statement on Form 1-A
File No. 024-11305

Dear Ms. Murphy:

On behalf of Monogram Orthopaedics, Inc., I hereby request qualification of the above-referenced offering statement at 12:00pm, Eastern Time, on Friday, January 15, 2021, or as soon thereafter as is practicable.

Sincerely,
/s/ Benjamin Sexson
Benjamin Sexson
Chief Executive Officer
Monogram Orthopaedics, Inc.

cc: Andrew Stephenson

CrowdCheck Law LLP

Field: Page; Sequence: 1; Options: Last

Field: /Page